EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Ultrasound With Contrast Enhancement for Reassessment of MRI‐Detected BI‐RADS 4 Nonmass Enhancement: Impact on Biopsy Reduction and DCIS Detection

Qinghua Niu iD, Ting Sun iD, Mingxuan Li iD, Lianfang Du iD, Yingyu Cai iD, Lifang Jin iD, Chao Jia iD, Hui Li iD, An Chen iD, Fan Li iD

The Breast Journal · 2026-01 · 2026 (1)

DOI: 10.1155/tbj/1932231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Breast Journal, online erschienen am 05.11.2026. Verfasst von Qinghua Niu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, shsmu.edu.cn. Hauptthemen laut MEDLINE: Breast Neoplasms, Magnetic Resonance Imaging, Carcinoma, Intraductal, Noninfiltrating, Ultrasonography, Mammary. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai Municipal Education Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate whether targeted ultrasound (TUS) combined with contrast‐enhanced ultrasound (CEUS) can safely reclassify MRI‐detected BI‐RADS 4 nonmass enhancement (NME) lesions to reduce unnecessary biopsies while maintaining high diagnostic sensitivity for breast cancer. Materials and Methods In this prospective study (2017–2023), we enrolled 169 MRI‐detected BI‐RADS 4 NME lesions in 167 women (23–84 years). All patients underwent TUS and CEUS within one week after MRI, followed by surgical pathology. We evaluated whether TUS combined with CEUS could reclassify lesions to avoid biopsy without compromising cancer detection.

Results

Among 169 lesions (83 benign, 86 malignant), TUS detected 97.0%. Using predefined CEUS benign criteria, 36/83 benign lesions (43.4%) and 39/169 overall (23.1%) could have safely avoided biopsy. Diagnostic sensitivity remained high (96.5%, 83/86). CEUS significantly improved detection of DCIS, upgrading 87.5% (21/24) of MRI‐BI‐RADS 4a DCIS/DCIS with microinvasion to BI‐RADS ≥4b. False‐negative cases were limited to three lesions in challenging anatomical locations (subareolar or occult). Biopsy reduction was highest in asymptomatic patients, lesions ≤ 2 cm, homogeneous enhancement, and MRI BI‐RADS 4a.

Conclusions

TUS combined with CEUS can substantially reduce unnecessary biopsies for MRI‐detected BI‐RADS 4 NME while maintaining excellent sensitivity. This approach is particularly effective for MRI BI‐RADS 4a lesions and small homogeneous NME and may provide a clinically practical strategy for improving diagnostic efficiency in breast cancer care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMagnetic Resonance ImagingCarcinoma, Intraductal, NoninfiltratingUltrasonography, MammaryHumansFemaleAgedMiddle AgedContrast MediaAged, 80 and overProspective StudiesAdultSensitivity and SpecificityBiopsyYoung Adult

Stichwörter der Autor:innen

BI-RADS 4DCISbiopsy reductionbreast MRIcontrast-enhanced ultrasoundnonmass enhancement

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Ultrasound, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, shsmu.edu.cn.
  • Department of Ultrasound, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China.
  • Department of Ultrasound, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, shsmu.edu.cn.
  • Department of Ultrasound, Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), Tongji University School of Medicine, Shanghai, China, tongji.edu.cn.
  • Department of Ultrasound, Huashan Hospital, Fudan University, Shanghai, China, fudan.edu.cn.
  • Department of Radiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, shsmu.edu.cn.

ORCID-Profile: Qinghua Niu, Ting Sun, Mingxuan Li, Lianfang Du, Yingyu Cai, Lifang Jin, Chao Jia, Hui Li, An Chen, Fan Li

Förderung

  • Shanghai Chest Hospital
  • Shanghai Jiao Tong University
  • Shanghai Municipal Education Commission
  • Songjiang District Science and Technology Research Project

Zitieren

APA

Niu, Q., Sun, T., Li, M., Du, L., Cai, Y., Jin, L., Jia, C., Li, H., Chen, A., & Li, F. (2026). Targeted Ultrasound With Contrast Enhancement for Reassessment of MRI‐Detected BI‐RADS 4 Nonmass Enhancement: Impact on Biopsy Reduction and DCIS Detection. The Breast Journal, 2026(1). https://doi.org/10.1155/tbj/1932231

Vancouver

Niu Q, Sun T, Li M, Du L, Cai Y, Jin L, et al. Targeted Ultrasound With Contrast Enhancement for Reassessment of MRI‐Detected BI‐RADS 4 Nonmass Enhancement: Impact on Biopsy Reduction and DCIS Detection. The Breast Journal. 2026;2026(1). doi:10.1155/tbj/1932231

BibTeX
@article{Niu2026,
  author = {Niu, Qinghua and Sun, Ting and Li, Mingxuan and Du, Lianfang and Cai, Yingyu and Jin, Lifang and Jia, Chao and Li, Hui and Chen, An and Li, Fan},
  title = {Targeted Ultrasound With Contrast Enhancement for Reassessment of MRI‐Detected BI‐RADS 4 Nonmass Enhancement: Impact on Biopsy Reduction and DCIS Detection},
  journal = {The Breast Journal},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/tbj/1932231}
}
Kostenlos starten →